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The role of surface immunoglobulin (Ig) in triggering B-lymphocyte  responses 
is not yet clear. For several years it has been known that anti-Ig antibodies can 
interfere with the activation of B cells by mitogens (1-5). Whether this block is 
external, interfering with the mitogenic receptor, or internal, affecting deeper 
features of the cells' metabolism, is not yet established. 
Anti-Ig antibodies have a  particularly deleterious effect on the immature B lympho- 
cyte (6), suggesting that surface Ig may control the state of  differentiation and activation 
of the B cell.  First, immature B cells do not re-express their surface Ig molecules after 
capping and clearance with anti-Ig antibodies even though they do so after the removal of 
surface Ig from the membrane by enzymes (7). Second,  after interaction with anti-Ig 
antibodies, immature B cells can no longer respond mitogenically to lipopolysaccharide 
(LPS) ~  (7). If  surface Ig molecules are required for the action of mitogens, the immature B 
cells' lack of surface Ig re-expression could explain their insensitivity to LPS after anti-Ig 
treatment. Alternatively, anti-Ig treatment could have changed the activation potential 
of the immature B cells in some other way. 
The present studies were undertaken in hopes of elucidating the nature and 
mechanism of the anti-Ig-induced blockage of mitogen responsiveness. We have 
designed experiments to examine the action of LPS on adult mouse B cells in the 
few hours after exposure to anti-Ig antibodies when surface Ig has been capped 
and cleared but before new surface Ig is expressed  (8).  This paper reports that 
rather than merely being the initial target of mitogen action, surface Ig mole- 
cules in cooperation with Fc receptors are fundamentally involved in controlling 
the internal state of activation of the B  lymphocyte. 
Materials and Methods 
Cells.  Adult (6-wk to 6-mo old) male and female C57BL/6 mice were used, either raised in our 
own facilities or purchased from The Jackson  Laboratories,  Bar Harbor,  Maine. Their spleens 
were removed and  teased  into the  standard  medium  of Hanks' balanced  salt  solution  (BSS) 
(Microbiological Associates,  Inc.,  Bethesda,  Md.) plus  1%  N-2-hydroxyethylpiperazone-N-2- 
ethane sulfonic acid (HEPES) (Microbiological  Associates) plus 5% fetal calf serum (FCS) (Associ- 
l Abbreviations used in this paper:  ALG, rabbit  anti-mouse lymphocyte antibodies; BSS, bal- 
anced salt solution; FCS, fetal calf serum; FITC, fluorescein isothiocyanate; GAMG, goat anti- 
mouse Ig;  GARG, goat  anti-rabbit  Ig;  HGG, human  IgG; LPS,  lipopolysaccharide; NWSM, 
nocardia water-soluble mitogen; PPD, purified protein derivative; RAMG, rabbit  anti-mouse Ig; 
RGG, rabbit IgG. 
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ated Biomedic Systems,  Inc., Buffalo, N. Y.). The cells  were washed three times before the 
experimental manipulations. 
Immunoglobulins.  The following antibodies were used: (a) rabbit anti-mouse Ig (RAMG),  a 
polyvalent antibody obtained by repeatedly immunizing rabbits with isolated  mouse Ig (9);  (b) 
goat anti-mouse Ig (GAMG), obtained similarly to (a);  (c) goat anti-rabbit  Ig (GARG), obtained 
similarly  to (a);  rabbit  IgG (RGG) was obtained from pooled normal rabbit serum; (d) rabbit  anti- 
mouse lymphocyte  antibodies (ALG),  obtained  by immunizing  rabbits with two intravenous 
injections  of  mouse thymocytes (10);  (e)  antibodies  to  mouse histocompatibility  antigens (anti-H-2) 
obtained by immunizing DBA/2 mice with C57BL/6 spleen cells  (10).  The serum contained high 
titers of antibodies to the specific H-2  b haplotype. 
The IgG was isolated from all of these antisera by ammonium sulfate fractionation and then a 
DEAE  column (for rabbit antisera) or a  preparative starch block electrophoresis.  F(ab')2 frag- 
ments  of RAMG,  GAMG,  and GARG  were  prepared  by  digestion  with  pepsin  (Worthington 
Biochemical Corp.,  Freehold,  N. J.) and purified on Sephadex G-200 (11).  They were tested for 
purity by Ouchterlony gel diffusion analysis. F(ab')2 reagents were considered pure when antisera 
against the appropriate  gamma globulin gave  a  spur with the  undigested reagent which ran 
directly towards the well containing the digested reagent. Fab fragments of RAMG were prepared 
by  papain  (Worthington  Biochemical)  digestion  and  purified  by  carboxymethylcellulose  (11). 
Finally, human IgG (HGG), obtained from Pentex Biochemical, Kankakee, Ill., was aggregated 
by heating for 1 h  at 63°C. 
Reagents.  The  following reagents  were  used:  sodium  azide  (Matheson,  Coleman,  &  Bell, 
Rutherford, N. J.); lipopolysaccharide-boivin, from Escherichia coli 0111:B4 (Difco Laboratories, 
Detroit, Mich.); nocardia water-soluble mitogen (NWSM)  (12)  obtained from Doctors Bona and 
Chedid of  the Pasteur Institute  in Paris, France; purified  protein derivative (PPD) (Connaught 
Medical Research Laboratory, Toronto, Canada); trypsin (TR-TPCK,  Worthington Biochemical); 
pronase (protease from Streptomyces griseus, Type VI) (Sigma Chemical Company,  St. Louis, 
Mo.); and RGG  and HGG  (Pentex Biochemical). 
Basic Experimental Procedure.  The basic experimental design consisted of incubating cells at 
a  concentration of 107/ml in standard medium or an antibody solution at 37°C  for 1 h.  (Unless 
otherwise stated, this initial incubation in anti-Ig was done with 200 fig per ml of RAMG.) The 
cells were washed three times at room temperature and resuspended in standard medium not 
containing any mitogen or containing 25/~g per ml of LPS (or optimal concentrations of other B- 
cell mitogens). After 1 h  at 37°C,  the cells were again washed three times at room temperature, 
counted,  and cultured in triplicate in 12  ×  75-mm plastic tissue culture tubes (Falcon Plastics, 
Oxnard,  Calif.).  Each  tube  contained  10  e  cells  in  1.0  ml  of RPMI-1640  with  penicillin  and 
streptomycin  (Associated  Biomedic Systems)  plus  5%  FCS  and  2  mM  L-glutamine.  The  tubes 
were incubated in a humidified 5% CO2 atmosphere at 37°C. After 24 h, 1 ~Ci of [3H]thymidine (2 
Ci  per mmol,  New  England  Nuclear,  Boston,  Mass.)  in  50  ~l  of RPMI-1640  was  added.  The 
incorporation of [3H]thymidine into trichloroacetic acid-insoluble material was determined 24 h 
later. All figures represent average results of at least three different experiments. 
Two-Step Antibody Treatments.  For experiments in which cells were incubated successively 
in two separate antibodies before being incubated with a  mitogen, the first antibody incubation 
was done at 4°C for 30 rain. The cells were then washed three times in cold medium, and the second 
antibody solution was added. The mixture was then brought to 37°C for 1 h for the second antibody 
incubation.  Further washes and manipulations were done as in the basic procedure described 
above. This procedure was used to prevent the cell from redistributing or clearing the first ligand 
before it was incubated in the second. 
Fluorescence  Studies.  All antibodies used were tested by fluorescence for binding to spleen 
cells. The following were directly fluoresceinated and tested in a one-step reaction: RAMG, RAMG 
F(ab')2, RAMG Fab, GAMG, GAMG F(ab')2, aggregated HGG, and RGG-anti-RGG (both fluores- 
ceinated). Two-step sandwich reactions were also used to detect the binding of unlabeled RAMG, 
RAMG F(ab')2, RAMG Fab, and ALG (FITC-GARG used as second layer) and anti-H-2 antibodies 
(FITC-RAMG used as second layer). For these tests, aliquots of cells at a  concentration of 107/ml 
were incubated with the first antibody (10-100  ~tg/ml) for 30 min at 4°C and then washed three 
times at 4°C.  If necessary, a second incubation was done with a fluorescent anti-antibody (50-100 
~tg/ml) for 30 rain at 4°C.  After three final washes at 4°C,  the cells were fixed by the addition of 
equal parts  medium  and  2%  paraformaldehyde.  After  15  min  at  room  temperature,  the  cells 884  CONTROL  OF  B-LYMPHOCYTE  FUNCTION 
were washed  once more and examined in a Leitz Ortholux fluorescent  microscope. All anti-Ig 
antibodies,  as well as heat-aggregated human gamma globulin  (agg-HGG) and RGG-anti-RGG 
complexes, label 40-45% of spleen  cells.  Anti-H-2  and ALG antibodies,  tested in a  sandwich 
reaction,  label 95-100% of the spleen cells. 
To test the capping behavior of anti-Ig antibodies  and their fragments, cells were incubated at 
4°C for 30 min with 50 ~g/ml of directly fluoresceinated  antibody.  After three washes at 4°C, the 
cells were warmed to 37°C for 10 min. They were then fixed with paraformaldehyde as above, 
washed,  and scored for percentage capped. Intact and F(ab')2 anti-Ig antibodies  capped at least 
75% of the stained cells, while Fab fragments capped less than 10%. 
Enzymatic Removal of Surface Ig.  Cells at a concentration  of 107 per ml were washed once in 
BSS and HEPES and then exposed to 1.5 mg per ml pronase in BSS plus HEPES for 60 min at 37°C. 
They were then washed three times at room temperature in the standard medium. By fluores- 
cence, this procedure  reduced  the percentage of spleen  cells staining with FITC-RAMG from 
approximately 50 to 5%. The remaining 5% detectable were stained extremely faintly, unlike 
control cells which were very brightly stained. 
Results 
Phenomenon of A nti-Ig-Induced Inactivation.  To study the relationship  be- 
tween surface Ig-anti-Ig interactions and the B-cell mitogenic response, we used 
a  system in  which cells were exposed to LPS in free solution  for only a  brief 
period of time.  Spleen cells incubated with 25 gg per ml of LPS for 1 h  at 37°C 
responded  with  15,000-20,000  cpm  of  [~H]thymidine  incorporated  into  DNA. 
This response was maximal when assayed at 48 h  and represented  about one- 
quarter of the response of cells cultured continuously in LPS. 
In agreement with others, we have found that anti-Ig inhibited the mitogenic 
response to LPS.  Fig.  1 shows that the  LPS response of cells pretreated with 
anti-Ig for  1  h  was  much  less  than  that  of control  cells.  Note  also  that  the 
background  (actually the  basal  mitogenic response to  FCS)  was similarly re- 
duced in the anti-Ig-treated cells.  Fig.  2 shows that the response to three other 
B-cell stimulators (two bacterial products-NWSM  and PPD, and one protease- 
trypsin) was similarly reduced by the anti-Ig pretreatment. Thus, the action of 
all  B-cell  stimulators  tested  was similarly inhibited  by anti-Ig.  For the  rest of 
this report, the response to LPS is considered as a model for all B-cell mitogens. 
Kinetic experiments were then performed to determine how long lasting is the 
state of inactivation produced by anti-Ig and under what circumstances can it be 
produced.  First,  it was  apparent that  the  inactivation  by anti-Ig persisted  in 
cells  examined  up  to  1  wk  (data  not  shown).  Thus  the  inactivation  was  not 
accounted for by a  simple shift in the kinetics of proliferation. Also, it was seen 
for pulses of LPS ranging in concentrations from 0.1 to 1,000 gg per ml (data also 
not shown). In the experiments shown in Fig. 3, the interval between the anti-Ig 
and LPS incubations was varied. The results show that the state of inactivation 
was quite long lasting,  not being significantly reversed by 36 h  after the anti-Ig 
treatment and still evident 48 h  afterwards. In contrast, the B cells' surface Ig is 
essentially completely re-expressed by 12 h  after the anti-Ig treatment  (8). 
In addition to pretreating cells with anti-Ig, the LPS mitogenic response was 
equally reduced by treating cells with anti-Ig after the LPS incubation (Table I). 
We then checked to see how long after the LPS pulse anti-Ig could be inhibitory. 
Fig. 4 shows that as the interval between the LPS and anti-Ig treatments was 
lengthened,  the inhibitory effects of anti-Ig became less evident. Anti-Ig added CHARLES  L.  SIDMAN  AND  EMIL  R.  UNANUE  885 
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FIG. i.  Anti-Ig inhibition of  basal proliferation  and of  LPS-stimulated mitogenesis. The 
basic experimental design is as detailed in Materials and Methods. In this and all subse- 
quent  figures  and tables,  values  reported  represent  the  combined means _+  standard  error  of 
the mean  from several individual  experiments.  E, experimental  (LPS stimulated); C, 
control (non-LPS stimulated). 
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FIG.  2.  Anti-Ig inhibition of basal and stimulated mitogenesis. These experiments were 
done as in Fig. 1, except that other B mitogens were used instead of LPS. NWSM, nocardia 
water-soluble mitogen (25  ~g per ml); PPD,  purified protein derivative (100  ~g per ml); 
trypsin (100 ~g per ml). 
in  the  middle  of the  [3H]thymidine  exposure  still  partially  suppressed  the 
incorporation of the radioactive precursor, however. 
Mechanism of  Inactivation.  A role for surface Ig molecules in LPS triggering 
has been proposed as a basis for the anti-Ig-induced inactivation of LPS mito- 
genesis (13). The simple removal from the membrane of the surface Ig molecules 
themselves does not appear to be the basis for this inactivation, however. Table I 
shows that stripping the cells of surface Ig by using the enzyme pronase did not 
block the subsequent stimulation by LPS. 886  CONTROL  OF  B-LYMPHOCYTE  FUNCTION 
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FIo.  3.  Kinetics of recovery from anti-Ig-produced inhibition of mitogenesis. After a  1-h 
incubation with anti-Ig, cells were incubated up to 48 h before being pulsed with LPS for I h. 
They were then put into culture, pulsed with [~H]thymidine 24 h later, and harvested 24 h 
later. The response of the anti-Ig-treated cells is represented as a percentage of the response 
of non-anti-Ig-treated cells manipulated in parallel as controls.  (In this and Fig. 4 points 
with a  star represent results of one experiment only.) 
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Fro.  4.  Inhibition by exposing ceils to anti-Ig after a pulse of LPS. After a  1-h incubation 
with LPS, cells were put into culture, pulsed with [~H]thymidine 24 h later, and harvested 
24 h later as described in Materials and Methods. 0, 12, or 24 h (i.e., immediately before the 
addition of [SH]thymidine) after the LPS incubation, cell aliquots were incubated with anti- 
Ig for 1 h  (cell concentrations were corrected to 10  ~ per ml) and replaced in culture. For the 
36 h point anti-Ig (for a final concentration of 200 ~g per ml) was simply added to the tubes 
already containing [aH]thymidine. The response of the anti-Ig-treated cells is reported as a 
percentage of the response of cells manipulated  in parallel  but exposed to medium  not 
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TABLE  I 
Relationship of Mitogenic Inhibition to Presence or Absence of 
Surface Ig 
First incubation  Second incubation  Mitogenic response 
(cpm per 10  ~ cells) 
Medium  Medium  8,773  _+  1,769 
Medium  LPS  25,082  +  2,611 
Anti-Ig  Medium  2,981  ±  583 
Anti-Ig  LPS  7,664  ±  1,210 
LPS  Medium  20,183  ±  5,632 
LPS  Anti-Ig  5,905  -  709 
Pronase  Medium  6,308  +-_  1,400 
Pronase  LPS  19,965  _  3,433 
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We next tested  several  other ligands  for their  effect on B-cell mitogenesis 
(Fig. 5). Of these, the most inhibitory was ALG which, at high concentrations, 
was almost as inhibitory as anti-Ig, although it was significantly less effective at 
lower concentrations. Immunoglobulin containing antibodies to the major histo- 
compatibility antigens (anti-H-2) yielded a weak inhibition of borderline signifi- 
cance at high concentrations.  Finally, neither normal rabbit gamma globulin 
(RGG, not shown), immune complexes (RGG-anti-RGG), nor agg-HGG gave any 
inhibition  at any concentration  tested.  Thus,  the inhibition  of mitogenesis is 
clearly not achieved by any ligand binding to the cell surface, but is restricted to 
only some. 
We then examined the contribution of the Fc portion of anti-Ig and the effects 
of cross-linking  in  this  inactivation.  Fig.  6  shows  that,  of various  anti-Ig 
antibody fragments,  intact  anti-Ig molecules were by far the most inhibitory. 
F(ab')2 fragments were weakly inhibitory, but about 20 times less so than intact 
molecules on a  molar basis. No inhibition was seen with Fab fragments at any 
concentration tested. 
The possible role of the classical sequence of patching, capping, and endocyto- 
sis of surface Ig-anti-Ig complexes in the inactivation process was then exam- 
ined. Since in Fig. 6 it was shown that F(ab')2 fragments of anti-Ig were much 
less effective inactivators than intact molecules, even though they capped and 
cleared the surface Ig equally as well (11; and confirmed in these experiments), 
capping of surface Ig alone could not be sufficient for this inactivation.  Fig.  7 
confirms that anti-Ig Fab and F(ab')2 fragments (of RAMG) were not inhibitory 
by themselves.  However, when cells that had been incubated with these anti- 
body fragments at 4°C and washed were then incubated at 37°C with doses of 
GARG known to produce redistribution of (RAMG) Fab anti-Ig,  the mitogenic 
response  was  deeply  inhibited.  In  two  other  experiments  (not  shown),  cells 
incubated first with anti-Ig (RAMG) F(ab')2 were then incubated with intact or 
F(ab')2  fragments  of GARG.  The  result  was  that  F(ab')~  GARG  fragments 
produced about 50%  of the  inhibition  as compared to the effect of undigested 
GARG. 888  CONTROL  OF  B-LYMPHOCYTE  FUNCTION 
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Inhibition of mitogenesis by other ligands. Cells were  pretreated  with these 
ligands before an LPS pulse. ALG and anti-H-2 globulin were used at 1,  10, 100, and 1,000 
/~g per ml. Aggregated HGG was used at 10,  100,  1,000,  and 10,000/~g per ml. Anti-RGG 
(GARG) (0.5, 5, 50, and 500/~g per ml) was combined with RGG at the optimum ratio for 
fluorescent staining of cells (one-tenth of the anti-RGG concentration, or 0.05, 0.5, 5, and 50 
/~g per ml. This approximates molar equivalence if one assumes that 1 out of 10 antibody 
molecules in the GARG preparation  is specific anti-RGG).  The mitogenic responses are 
expressed as a percentage of the LPS-stimulated mitogenic response of cells pretreated only 
with standard medium. The tool wt used for gamma globulins was 150,000  daltons. 
Since capping of  surface Ig was not sufficient to produce the inhibition of DNA 
synthesis, we next asked if the classical capping and clearing sequence was 
necessary to produce it. To do this, we let anti-Ig interact with cells in normal 
medium or in the presence of sodium azide,  a  reversible metabolic inhibitor 
which prevents capping and endocytosis of surface complexes (14). At the end of 
the incubation with anti-Ig, we stripped the cells of surface Ig-anti-Ig complexes 
by  incubation with the  proteolytic enzyme pronase  (also  in  the  presence  of 
azide). Thus, the cells had interacted with anti-Ig in conditions that either did or 
did not allow capping and interiorization. 
Fig. 8 presents the results of these experiments. Control cells first treated 
with azide and then with pronase were slightly inhibited. Cells treated with 
anti-Ig and then with pronase were as deeply inhibited as those treated with 
anti-Ig, but without the pronase step. When the cells were incubated with anti- 
Ig in the presence of azide and then exposed to pronase to remove the complexes 
before they could cap and endocytose, the inhibition observed was significantly 
deeper than that produced by anti-Ig alone. Capping and endocytosis of surface 
Ig-anti-Ig complexes was,  therefore,  neither sufficient nor even necessary to 
produce inhibition. In fact, preventing this normal sequence resulted in a deeper 
and more profound inhibition. CHARLES  L.  SIDMAN  ANn  EMIL  R.  UNANUE  889 
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FIG.  6.  Inhibition  of mitogenesis  by anti-Ig fragments.  Before  an LPS pulse,  cells were 
pretreated with F(ab')2 and Fab anti-Ig molecules (of RAMG and GAMG) at 1, 10, 100, and 
1,000 ~g per ml. Mol wts of 150,000,  106,000,  and 56,000 daltons were used, respectively, to 
calculate the molar concentrations.  The mitogenic responses are expressed as percentages 
as in Fig.  5. 
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FIo.  7.  Inhibition of mitogenesis by capped anti-Ig fragments.  Except for anti-Ig (200/~g 
per ml), all reagents were used at 100 ~g per ml. As described in Materials and Methods, the 
first  of two  preincubations  was  done  at  4°C.  The  mi~ogenic  responses  are  expressed  as 
percentages as in Fig. 5. 
These  results  suggest  that  an  antibody  Fc  end,  rather than  capping  and 
endocytosis of surface Ig-anti-Ig complexes, facilitates the anti-Ig-induced inhi- 
bition of B-cell mitogenesis. Our data present several arguments that surface Ig 
and Fc receptor interactions together result in optimal inhibition. First, in Figs. 
5 and 6, it was shown that neither anti-Ig fragments lacking the Fc end, immune 890  CONTROL  OF  B-LYMPHOCYTE  FUNCTION 
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Fro.  8.  Role of capping and endocytosis in anti-Ig inhibition of mitogenesis. Pr,  pronase 
(1.5 mg per ml in BSS plus HEPES); Az, sodium azide (2 ×  10  -2 M in standard medium); Az 
+  Pr (1.5 mg per ml pronase plus 2  ×  10  -2 M azide in BSS and HEPES); Az +  aIg (2.5 x  10  -2 
M  azide in standard medium for 15 min at 37°C then 200/~g per ml RAMG plus 2  x  10  -2 M 
azide). All incubations shown were for 60 min at 37°C. Before any incubation with pronase, 
the cells were washed once in the same medium lacking pronase (i.e., BSS plus HEPES  ___ 
azide).  Before the LPS incubation, all cells were washed twice, purified on Ficoll-Hypaque 
gradients, and washed three times more. Mitogenic responses are expressed as percentages, 
as in Fig.  5. 
complexes, nor aggregated gamma globulins produced a very good inhibition by 
themselves.  Secondly,  the  second  (sandwich)  layer  of GARG  antibody  only 
yields  a  deep  inhibition  if it  is  added  to  the  proper  first  layer  of (anti-Ig) 
antibody. Fig. 9 shows that the same concentration of GARG which yielded the 
deep inhibition  with anti-Ig Fab or F(ab')2 (Fig.  7) did not give any additional 
inhibition  with a  moderately inhibitory  dose of ALG as the  first  layer,  even 
though by fluorescence it appeared that at least as much GARG had bound to 
ALG as to the anti-Ig fragments.  (The moderately inhibitory dose of ALG was 
chosen because it should have very sensitively revealed any additional effect of 
the second layer of GARG.) 
Finally, in two experiments (not shown), we have incubated cells simultane- 
ously with anti-Ig F(ab')2 antibody fragments and soluble immune complexes. 
No inhibition due to cooperation was observed. Thus, it is possible that both its 
surface Ig molecules and  Fc receptors must be cross-linked or present  in the 
same molecular complex to optimally inactivate the B cell. 
Discussion 
In the first section of this paper, we have shown that the classical surface and 
cytoplasmic cycle of  binding, patching, capping, endocytosing, and finally resyn- 
thesizing and re-expressing surface Ig does not leave the B lymphocyte as it was 
initially.  Even though it has regenerated  its receptors and appears to be the 
same,  it is no longer the cell it once was,  as evidenced by the fact that it no 
longer responds well to a short exposure to mitogen. This state of inactivation is CHARLES  L.  SIDMAN  AND  EMIL  R.  UNANUE  891 
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quite long lasting,  enduring for several days in vitro, beyond which it was not 
practical  to carry out the  experiments.  In contrast,  within  1 h  at 37°C,  the  B 
lymphocyte completely clears its membrane of surface Ig-anti-Ig complexes and 
has fully re-expressed them in about 12 h  (8). 
Given the fact that  a  single  cycle with anti-Ig  severely and  long lastingly 
inactivates  a  B  cell,  how can one reconcile previously published results that, 
after 1- or 24-h incubations  with anti-Ig,  normal  adult B  cells are  still  able to 
respond vigorously to LPS (3, 7)? In those past studies, cells were incubated with 
LPS continuously  after  the  anti-Ig  treatment,  whereas  here  they were  only 
given a  limited  exposure to LPS.  In both protocols,  all of the cells that  were 
exposed to LPS had  been reacted  with anti-Ig  and,  presumably,  inactivated, 
although  a  limited  number  were  still  able  to  divide.  We  suggest  that  the 
difference between the two systems occurred at this point, that the few new cells 
emerging from the first, limited round of division had little or no "memory" of 
the anti-Ig-induced suppression, and thus were able to proliferate normally or 
even better upon further LPS exposure, if it was still present to trigger them. 
Certain earlier reports concerning the anti-Ig-induced inhibition of the mito- 
genic response to LPS have suggested that surface Ig molecules may be involved 
in cell triggering,  or even that they are the mitogen receptors themselves (13). 
Thus the  modulation  of surface  Ig by anti-Ig  antibody would make  the  cells 
refractory to LPS stimulation. Four reasons make this unlikely, however. First, 
as has been previously reported (4),  anti-Ig can block the LPS response even if 
given after the LPS exposure.  Second, the direct removal of surface Ig by the 
enzyme pronase does not block the LPS response. Third, removal of surface Ig by 
anti-Ig F(ab')2 fragments leaves the cell still functional. Fourth, anti-Ig inhibits 
the  mitogenic  response  to  all  B-cell  stimulators  tested,  even  to  the  enzyme 
trypsin (see also 3-5). The fact that the response to different B-cell mitogens is 
independently  genetically  controlled,  apparently  at  the  membrane  receptor 
level (15),  implies that  various mitogens have different membrane  receptors. 
Surface Ig molecules could not be identical  to a  number of different mitogen 
receptors. For all these reasons, it appears that the anti-Ig-induced inhibition of 892  CONTROL  OF  B-LYMPHOCYTE  FUNCTION 
the B-cell mitogenic response occurs at some intracellular level and is independ- 
ent of the presence or absence of surface Ig. 
One of the major conclusions of this paper is that the classical B-cell reaction 
of capping and endocytosing surface Ig-anti-Ig complexes is not necessary for the 
delivery of the negative signal for mitogenesis.  Indeed, the signal is delivered 
efficiently if capping and endocytosis are prevented. The fact that the inhibition 
still occurs even when the complexes are enzymatically stripped from the cell 
without allowing capping and endocytosis to occur at all proves that the nega- 
tive signals  are truly trans-membrane  signals.  Ligand-receptor  complexes do 
not themselves have to be internalized to signal the cell that the interaction has 
taken place. 
These findings  also allow a  new interpretation  of the  B  cell's capping  and 
endocytosing  response  to  ligand  interactions.  In  addition  to  other  possible 
functions, we would like to suggest that this response is the B cell's attempt to 
rid  itself of a  membrane  perturbation.  If signals  are  delivered to the cell by 
activated  (perhaps  cross-linked)  receptors on the cell surface,  removing these 
activated receptors by capping and endocytosis might damp down and terminate 
the signal. Conversely, a ligand-receptor complex that is not readily capped and 
endocytosed might deliver the most powerful signal.  The possibility that posi- 
tive as well as negative signals are similarly affected (reduced) by the B cell's 
capping and endocytosing response might partially explain the special immuno- 
genicity of macrophage-bound  antigen  (16),  as well as the distinctly different 
effects on mouse B  cells of the soluble vs.  the insoluble forms of anti-Ig  (17), 
antigen  (18,  19), immune complexes (20), phytohemagglutinin  (21), and concan- 
avalin A  (22). 
The studies on ligand specificity reported here show that the optimal inactiva- 
tion occurs with intact anti-Ig antibody or with anti-Ig fragments cross-linked 
by a second antibody containing an Fc end.  (The inactivation with ALG at high 
doses remains unexplained.  ALG is a crude antibody reacting presumably with 
various  surface  macromolecules,  besides  remaining  surface  bound  for  long 
periods of time.)  This suggests that  the B-cell Fc receptor may serve mainly a 
negative, or inhibitory,  role.  While no inhibition was seen with aggregated or 
antigen-complexed immunoglobulins,  others have observed an inhibition of B- 
cell mitogenesis by insolubilized immune complexes (20).  That system differed 
from the one reported here in that the immune complexes were immobilized onto 
plastic dishes (and thus were nonendocytosable by the B cells) and were present 
for the entire  mitogen incubation.  These factors may have augmented the Fc 
receptor interaction  and  allowed it alone to inhibit the mitogenic response in 
that  system.  In  contrast,  we have  shown  here  that  Fc  receptor  interactions 
delivered  alone  via  soluble molecules are  ineffective unless  accompanied  by 
surface Ig binding as well. It may be that bringing surface Ig molecules and Fc 
receptors into close proximity produces the maximum negative effect of the Fc 
receptors.  Two  possible  mechanisms  for  this  could  be  the  production  of an 
optimal cooperative association of Fc receptors themselves or a  true two-mole- 
cule association between Fc receptors and surface immunoglobulins  along the 
lines of the hormone receptor for insulin (23). In any case, these data emphasize 
the requirement for surface Ig binding in producing the optimal (Fc receptor ?) CHARLES  L.  SIDMAN  AND  EMIL  R.  UNANUE  893 
inactivation. This is presumably the physiological situation occuring with antl- 
gen. 
Other papers on the suppressive effects of anti-Ig antibody have shown that 
F(ab')~ fragments were as effective as intact antibodies for the suppression of the 
PFC response (3) and for antibody production (24). In contrast, we show in our 
system that on a molar basis F(ab')2 fragments are about 20 times less effective 
than intact molecules. Two points should be mentioned regarding these differ- 
ences. First, those systems in which F(ab')2 anti-Ig is equally effective are more 
complicated than the current one, involving cell differentiation and division, as 
opposed  to just  division.  It  may  be  that  Fc  receptor  as  well  as  surface  Ig 
interactions are needed to inhibit B cell division, but that surface Ig interactions 
alone can inhibit certain differentiation processes. Second, even the fact that in 
our system of mitogenesis certain anti-Ig antibodies without Fc ends can have 
an inhibitory effect may still be due to an Fc receptor cooperation. It has been 
shown that the interaction  of anti-Ig  F(ab')2 fragments with surface Ig mole- 
cules induces  a  degree of association  with  Fc receptors  (11),  presumably  via 
interactions with the surface Ig's own Fc ends. Perhaps a strong enough anti-Ig 
binding,  either with enough anti-Ig F(ab')2 or with extra cross-linking such as 
with GARG F(ab')2, even though without an external Fc end, can inactivate the 
B cell by using the Fc end of the surface Ig molecules themselves. 
A number of facts concerning immunological tolerance are consistent with the 
two main  considerations  emphasized  here,  Fc receptors and  capping/clearing 
behavior. First, it is known that gamma globulins used as antigens or carriers 
for haptens  are  among  the  most  effective tolerogens  (25).  This  could be due 
simply  to  the  fact  that  they  carry  an  Fc  end  of their  own  which  can  help 
inactivate specific B cells. Second, immune complexes have been reported to be 
both  suppressive  and  stimulatory  in  the  immune  response  (26).  To be  truly 
suppressive, the antibody involved has been shown to require an Fc end  (27), 
indeed  one  that  binds  to  Fc receptors  (26).  This  suppression  may,  therefore, 
operate  via  the  process  discussed here.  Finally,  in  certain  systems of B-cell 
tolerance,  antigens have been shown to remain on the cell surface for several 
hours before they are completely removed (POL [28]),  or to remain essentially 
forever (D-GL [29]). In contrast, protein antigens are completely eliminated from 
the cell surface in a matter of minutes (8). Perhaps antigens like POL and D-GL 
are easily tolerogenic in part because they linger so long on the B-cell surface 
and at the proper dose are able to deliver a sustained negative signal, possibly 
utilizing the Fc end of the surface Ig as discussed above. 
Our results should now be integrated with the broader field of B-cell trigger- 
ing  in  general.  In  our view,  the  paramount  fact  of B-cell  activation  is  that 
surface Ig molecules play a central role in controlling the cell's functions. This is 
in direct contrast to the view that surface Ig molecules merely passively "focus" 
antigens  to  the  cell  (30).  By  themselves,  surface  Ig  interactions  are  either 
suppressive  (for  differentiation?  as  discussed  above)  or  are  stimulatory  in  a 
limited fashion,  for mitogenesis only.  (Rabbit B cells are mitogenically stimu- 
lated by soluble anti-Ig [31],  as are mouse B cells by insolubilized anti-Ig [17].) 
As shown here,  when combined with  Fc receptor interactions,  the  surface Ig 
interaction  is  strongly  inhibitory  for  mitogenesis.  On  the  other  hand,  when 894  CONTROL  OF  B-LYMPHOCYTE  FUNCTION 
accessory cell activities are properly provided, the surface Ig interaction allows 
differentiation to secreting plasma cells (32). Thus, the end result of interactions 
with surface  Ig molecules depends critically  on the  modulating  influences  of 
other cells and molecules. 
Only a  hint  is yet possible of the  temporal  and  sequential  relationships  of 
these  various  B-cell  states.  For  activation  to  secreting  PFC,  accessory  cell 
factors are optimally provided 24 h  after anti-Ig (32), perhaps because the cells 
have developed receptors for these factors (33). During this sequence, enzymatic 
changes  are  then  seen  within  hours  (34)  which  indicate  that  the  B  cell  has 
embarked on the differentiative pathway which, in several more days, will yield 
a  PFC response. The data in this report have shown that the inactivated state 
brought about by a single cycle of anti-Ig antibodies is of long duration and is not 
indicated  by any  lack  of surface  Ig  molecules.  But  is  this  cell  permanently 
disabled or merely incompletely activated? B cells "tolerized" by D-GL (35) and 
SIII (36) are rescued and indeed activated to produce PFC by the proper action of 
T cells. It is possible that, for at least some period of time, B cells inactivated by 
the process described here are susceptible to rescue and further activation  by 
accessory cell influences. The relationship of this inactivation process and state 
to the activation pathway is currently under investigation. 
Summary 
Mouse spleen cells were incubated  with anti-Ig  antibodies for 1 h,  washed, 
exposed to LPS for 1 h,  washed, and their DNA synthetic responses assayed 2 
days later.  It was shown that the  1-h incubation  with anti-Ig antibodies pro- 
duced a profound, internal,  and long lasting state of inactivation in the B cells. 
Experiments with anti-Ig fragments and other ligands showed that the inactiva- 
tion occurred optimally when both surface Ig molecules and Fc receptors were 
bound simultaneously. The role of the classical capping and clearing cycle was 
also investigated.  It was shown that capping and clearing were neither neces- 
sary nor sufficient for the inactivation to occur, and that the signals,  but only 
secondarily  the  ligands  themselves,  were transmitted  across the  membrane. 
Capping and clearing were viewed as a natural regulatory mechanism by which 
the B cell attempts to clear its membrane of perturbations and signals from the 
exterior. 
Received for publication 24 May 1976. 
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